 Benitec Biopharma ASX: BLT, NASDAQ: BNTC Benitec or the Company, a biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference ddRNAi platform combining RNA interference with gene therapy, today announced that in accordance with Australian Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 Cth, the shareholder resolution to redomicile Benitec to the USA was passed. 